TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10831478

Group type: EXPERIMENTAL
Intervention: Venlafaxine XR (75, 150, or 225 mg/day)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 377
Study: 9335387

Group type: EXPERIMENTAL
Intervention: 1.0 mmol/L dialysate calcium
Number of subjects: 14

Group type: COMPARATOR
Intervention: 1.25 mmol/L dialysate calcium
Number of subjects: 14
Study: 8382725

Group type: EXPERIMENTAL
Intervention: RRVxDS-1 (serotype 2 vaccine)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: RRVxD (serotype 1 vaccine)
Number of subjects: 25
Study: 2875673

Group type: EXPERIMENTAL
Intervention: 6 different premedications
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Higher anxiety levels in patients
Number of subjects: 600
Study: 31556677

Group type: EXPERIMENTAL
Intervention: Oxytocin (OT) 40 IU
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30646043

Group type: EXPERIMENTAL
Intervention: Machine learning model predicting 30-day mortality from chemotherapy start
Number of subjects: 26946

Group type: EXPERIMENTAL
Intervention: Machine learning model predicting 30-day mortality among patients receiving palliative chemotherapy
Number of subjects: 26946

Group type: EXPERIMENTAL
Intervention: Machine learning model predicting 180-day mortality
Number of subjects: 26946
Study: 26132048

Group type: EXPERIMENTAL
Intervention: Music intervention offered once a day for 3 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group receiving routine care
Number of subjects: 100
Study: 24754143

Group type: EXPERIMENTAL
Intervention: Locked plate fixation for 3-part fractures
Number of subjects: 64

Group type: COMPARATOR
Intervention: Locked plate fixation for 4-part fractures
Number of subjects: 64
Study: 23127308

Group type: EXPERIMENTAL
Intervention: Group physiotherapy intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 111
Study: 21281126

Group type: EXPERIMENTAL
Intervention: Mindfulness meditation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: iMINDr (custom monitoring software)
Number of subjects: 11
Study: 17538544

Group type: EXPERIMENTAL
Intervention: 50 000 IU vitamin A with BCG vaccination
Number of subjects: 2145

Group type: COMPARATOR
Intervention: Placebo with BCG vaccination
Number of subjects: 2145
Study: 16750701

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 1095

Group type: COMPARATOR
Intervention: Conventional medical care
Number of subjects: 1095
Study: 12691339

Group type: EXPERIMENTAL
Intervention: Weight reduction programme (10% weight loss)
Number of subjects: 57
Study: 10891823

Group type: EXPERIMENTAL
Intervention: Adolescents
Number of subjects: 127

Group type: COMPARATOR
Intervention: Preadolescents
Number of subjects: 127
Study: 8937963

Group type: EXPERIMENTAL
Intervention: Azole resistant strains of Candida
Number of subjects: 64

Group type: COMPARATOR
Intervention: Azole susceptible strains of Candida
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Previous use of azole therapy
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: More than five episodes of oral candidosis in the last year
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: C2-3 category of HIV infection
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Low number of circulating CD4+ T-cells
Number of subjects: 64
Study: 1529684

Group type: EXPERIMENTAL
Intervention: Desmopressin 0.3 micrograms/kg BW
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 2868748

Group type: COMPARATOR
Intervention: Fenoldopam 25, 50, or 100 mg (dose-ranging study)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Fenoldopam 100 mg (double-blind study)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Fenoldopam 100 mg (after 1 month of 4 times daily dosing)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (double-blind study)
Number of subjects: 13
Study: 30388041

Group type: EXPERIMENTAL
Intervention: Stressful period (one week prior to an examination)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Nonstressful period (four weeks after an examination)
Number of subjects: 50
Study: 27254809

Group type: EXPERIMENTAL
Intervention: CLEAR CARE
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: OPTI‐FREE PureMoist
Number of subjects: 38

Group type: COMPARATOR
Intervention: Biotrue
Number of subjects: 38

Group type: COMPARATOR
Intervention: RevitaLens OcuTec
Number of subjects: 38
Study: 24858821

Group type: EXPERIMENTAL
Intervention: Cloxacillin 4 g i.v. (intervention group)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Healthy controls (control group)
Number of subjects: 8
Study: 21812009

Group type: EXPERIMENTAL
Intervention: Active exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 20
Study: 20170904

Group type: EXPERIMENTAL
Intervention: Incremental Theory highlighting the possibility of self-improvement
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study: 18247077

Group type: EXPERIMENTAL
Intervention: ATS mechanical aortic valve
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Carbomedics mechanical aortic valve
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: St Jude Medical Hemodynamic Plus mechanical aortic valve
Number of subjects: 300
Study: 18439587

Group type: EXPERIMENTAL
Intervention: Single medium
Number of subjects: 79

Group type: COMPARATOR
Intervention: Sequential media system
Number of subjects: 79
Study: 16355079

Group type: EXPERIMENTAL
Intervention: HRC PNF stretching
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: CRC PNF stretching
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study: 11258691

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) DPI, 100 microg, twice daily
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) DPI, 200 microg, twice daily
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) MDI, 168 microg, twice daily
Number of subjects: 227

Group type: COMPARATOR
Intervention: Placebo DPI
Number of subjects: 227
Study: 9610859

Group type: EXPERIMENTAL
Intervention: Disinfection solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 0
Study: 7799651

Group type: EXPERIMENTAL
Intervention: Slow-rapid reinforcing-reducing method
Number of subjects: 85

Group type: COMPARATOR
Intervention: Flat twisting method
Number of subjects: 85
Study: 3389317

Group type: EXPERIMENTAL
Intervention: Aerobic walking program during gestational weeks 22‐30 (n = 18)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nonwalking group (n = 10)
Number of subjects: 28
Study: 30877622

Group type: EXPERIMENTAL
Intervention: DFN-02 (sumatriptan 10 mg nasal spray)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 30118887

Group type: EXPERIMENTAL
Intervention: Training in Mental Imagery (TMI)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control Training in Verbal Thinking (TVT)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Waiting-list Control Group
Number of subjects: 111
Study: 27342433

Group type: EXPERIMENTAL
Intervention: Responsive stimulation plus enhanced nutrition
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Responsive stimulation alone
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: Enhanced nutrition alone
Number of subjects: 1302

Group type: EXPERIMENTAL
Intervention: All interventions (responsive stimulation plus enhanced nutrition, responsive stimulation alone, enhanced nutrition)
Number of subjects: 1302

Group type: COMPARATOR
Intervention: Routine health and nutrition services (control)
Number of subjects: 1302
Study: 24969395

Group type: EXPERIMENTAL
Intervention: BAILAMOS Latin dance program (4-month program, 2 times per week, 1 hour per session)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Health education control group (1 time per week, 2 hours per session)
Number of subjects: 332
Study: 22145610

Group type: EXPERIMENTAL
Intervention: ABT-594 150 μg
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: ABT-594 225 μg
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: ABT-594 300 μg
Number of subjects: 266

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 266
Study: 20074276

Group type: EXPERIMENTAL
Intervention: Interferon gamma (IFN‐γ)
Number of subjects: 0
Study: 17609872

Group type: EXPERIMENTAL
Intervention: Irradiation alone (50.4 Gy; 5 x 1.8 Gy/week)
Number of subjects: 19
Study: 16126756

Group type: EXPERIMENTAL
Intervention: Modified hypo-osmotic swelling (HOS) test
Number of subjects: 79

Group type: COMPARATOR
Intervention: Morphology selection
Number of subjects: 79
Study: 12229137

Group type: EXPERIMENTAL
Intervention: 2% lidocaine 1.5 mg.kg‐1
Number of subjects: 31

Group type: COMPARATOR
Intervention: Normal saline 0.75 ml.kg‐1
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Both groups (L and C)
Number of subjects: 31
Study: 10212082

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (250 microg/puff, two puffs, 12 hourly for 14 days)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53

Group type: COMPARATOR
Intervention: Fluticasone propionate and Placebo
Number of subjects: 53
Study: 7752567

Group type: EXPERIMENTAL
Intervention: Paper-and-pencil test (P & P)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Computerized adaptive test (CAT)
Number of subjects: 377

Group type: COMPARATOR
Intervention: Traditional success rate in adaptive testing
Number of subjects: 377
Study: 2157354

Group type: EXPERIMENTAL
Intervention: 2% nedocromil sodium eye drops
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 126
Study: 37542

Group type: EXPERIMENTAL
Intervention: Flurazepam 30 mg
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29774510

Group type: EXPERIMENTAL
Intervention: Culturally tailored video aimed at increasing enrollment in the Incredible Years® Parent Program
Number of subjects: 215
Study: 27687307

Group type: COMPARATOR
Intervention: ACF (Adriamycin 35 mg/m2, cisplatin 70 mg/m2 i.v. on day 1, fluorouracil 700 mg/m2 continuous infusion for 7 days) every 4 weeks
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: DCF (docetaxel 70 mg/m2, cisplatin 70 mg/m2 i.v. on day 1, fluorouracil 700 mg/m2 continuous infusion for 5 days) every 3 weeks
Number of subjects: 162
Study: 25831100

Group type: EXPERIMENTAL
Intervention: Reach PP‐‐entangled polypropylene floss
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Reach NT‐‐texturized nylon
Number of subjects: 10
Study: 23403978

Group type: EXPERIMENTAL
Intervention: Automated telephone calls followed by letters for continued nonadherence
Number of subjects: 5216

Group type: COMPARATOR
Intervention: No outreach (Control)
Number of subjects: 5216
Study: 21549403

Group type: EXPERIMENTAL
Intervention: Operative repair (laparoscopic mesh placement)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nonoperative treatment (physiotherapy, corticosteroid injections, oral anti-inflammatory analgesics)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Operative repair
Number of subjects: 60
Study: 19140899

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Intensive insulin injection therapy (IIT)
Number of subjects: 42
Study: 17728425

Group type: EXPERIMENTAL
Intervention: Mental health court program
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Successful completion of the mental health court program
Number of subjects: 170

Group type: COMPARATOR
Intervention: Standard criminal justice process (Control)
Number of subjects: 170
Study: 15166130

Group type: EXPERIMENTAL
Intervention: Modified ICSI (mICSI)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 70
Study: 12225513

Group type: EXPERIMENTAL
Intervention: Multi-component intervention (regulations enforcement, face-to-face education, peer influence)
Number of subjects: 22
Study: 22462215

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 60
Study: 7974375

Group type: EXPERIMENTAL
Intervention: Mononuclear cells from lymphoma patients after 20 h incubation at 37 degrees C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Culture medium from lymphoma patients' mononuclear cells after 20 h incubation at 37 degrees C
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Plasma from lymphoma patients
Number of subjects: 12
Study: 2648867

Group type: EXPERIMENTAL
Intervention: Desipramine 200 mg/day
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 4580022

Group type: EXPERIMENTAL
Intervention: Lowering diastolic blood pressure levels of between 100 and 120 mm Hg to below 100 mm Hg.
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control group (not specified treatment).
Number of subjects: 58
Study: 30872263

Group type: EXPERIMENTAL
Intervention: Enzalutamide with androgen-deprivation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with androgen-deprivation therapy
Number of subjects: 0
Study: 28003557

Group type: EXPERIMENTAL
Intervention: Hyperoxygenation with FIO2 + 0.20 above baseline
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Hyperoxygenation with FIO2 1.0
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (baseline values)
Number of subjects: 68
Study: 25531343

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 4640

Group type: EXPERIMENTAL
Intervention: Emtricitabine-tenofovir disoproxil fumarate (FTC-TDF)
Number of subjects: 4640

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4640

Group type: COMPARATOR
Intervention: All groups (TDF, FTC-TDF, and placebo)
Number of subjects: 4640
Study: 23239133

Group type: EXPERIMENTAL
Intervention: Reboxetine (4 mg/day) + Betahistine (48 mg/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 22403954

Group type: EXPERIMENTAL
Intervention: Combined central and local application of physiotherapeutic techniques (using AVIM‐1 apparatus for vibration and magnetic field application, and AMO‐ATOS‐E device for transcranial magnetotherapy and electrostimulation)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Combined central and local application of physiotherapeutic techniques
Number of subjects: 98
Study: 18613281

Group type: EXPERIMENTAL
Intervention: Progressive Resistance Training (PRT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting-list comparison group
Number of subjects: 45
Study: 17704973

Group type: EXPERIMENTAL
Intervention: Hypericum extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synthetic antidepressive drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Somatoform disorders
Number of subjects: 0
Study: 15540297

Group type: EXPERIMENTAL
Intervention: Laparoscopic resection
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventional resection
Number of subjects: 26
Study: 11080605

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy with nutritional approach
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cognitive-behavioural therapy without nutritional approach
Number of subjects: 60
Study: 9846846

Group type: EXPERIMENTAL
Intervention: Stearic acid-rich triacylglycerol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Palmitic acid-rich diet
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 15

Group type: COMPARATOR
Intervention: Habitual diet (before study)
Number of subjects: 15
Study: 7522088

Group type: EXPERIMENTAL
Intervention: N2 flow
Number of subjects: 100

Group type: COMPARATOR
Intervention: no N2 flow
Number of subjects: 100
Study: 2628134

Group type: EXPERIMENTAL
Intervention: Atropine (12 micrograms/kg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cimetropium bromide (5 mg)
Number of subjects: 20
Study: 972260

Group type: EXPERIMENTAL
Intervention: P-300
Number of subjects: 26

Group type: COMPARATOR
Intervention: 3% hexachlorophene preparation
Number of subjects: 26
Study: 30699420

Group type: EXPERIMENTAL
Intervention: MDT care based on 5E's renal rehabilitation
Number of subjects: 146

Group type: COMPARATOR
Intervention: Routine care and follow‐up (Control)
Number of subjects: 146
Study: 26214543

Group type: EXPERIMENTAL
Intervention: Children of Divorce‐Coping With Divorce (CoD‐CoD)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Internet self‐study condition, Best of the Net (BTN)
Number of subjects: 147
Study: 23743482

Group type: EXPERIMENTAL
Intervention: 12-weekly LSC videos
Number of subjects: 238

Group type: COMPARATOR
Intervention: 12-weekly HIV prevention messages
Number of subjects: 238
Study: 21291434

Group type: EXPERIMENTAL
Intervention: Parental support for fighting
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Parental support for nonviolence
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Parental involvement
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Class-level norms supporting aggression
Number of subjects: 5581

Group type: EXPERIMENTAL
Intervention: Delinquent peer associations
Number of subjects: 5581
Study: 19271169

Group type: EXPERIMENTAL
Intervention: Quyu Jiedu Granules (QJG)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 20
Study: 16620350

Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil 8 mg
Number of subjects: 256

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 256

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 256
Study: 14711910

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (100 mg daily)
Number of subjects: 518

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study: 15006431

Group type: EXPERIMENTAL
Intervention: Pindolol 7.5 mg
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 10885352

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg zinc per day as zinc sulphate, 6 days a week for 6 months)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 9184265

Group type: EXPERIMENTAL
Intervention: Interleukin-10 (IL-10)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Interleukin-6 (IL-6)
Number of subjects: 108

Group type: COMPARATOR
Intervention: C-reactive protein (CRP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Alpha-1-acid glycoprotein (AGP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Alpha1 antichymotrypsin (ACT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IL-10 and APP correlation
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IL-6 and APP correlation
Number of subjects: 108
Study: 8238640

Group type: EXPERIMENTAL
Intervention: Haloperidol (up to 6 mg/day)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Phenelzine (up to 90 mg/day)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 3804176

Group type: EXPERIMENTAL
Intervention: ranitidine 150 mg bd
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg bd
Number of subjects: 20
Study: 3288675

Group type: EXPERIMENTAL
Intervention: Ultrafast computed tomography
Number of subjects: 62
Study: 30307840

Group type: EXPERIMENTAL
Intervention: Randomized feedback threatening masculinity
Number of subjects: 867
Study: 30326764

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 101
Study: 28455782

Group type: EXPERIMENTAL
Intervention: RPC4046
Number of subjects: 0
Study: 25748117

Group type: EXPERIMENTAL
Intervention: Mitomycin C (MMC) followed by monthly bacillus Calmette-Guérin (BCG) instillations
Number of subjects: 236

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) followed by alternating BCG and interferon (IFN)-α2b instillations
Number of subjects: 236
Study: 23379741

Group type: EXPERIMENTAL
Intervention: Case Management (CM)
Number of subjects: 278

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 278
Study: 21393298

Group type: EXPERIMENTAL
Intervention: Eplerenone 25-50 mg/day
Number of subjects: 6632

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6632

Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 6632
Study: 19957509

Group type: EXPERIMENTAL
Intervention: Alendronate
Number of subjects: 8610
Study: 17123125

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 15543449

Group type: EXPERIMENTAL
Intervention: Three-lens image-shifting mechanism combined with software designed to track nystagmus.
Number of subjects: 12
Study: 11237896

Group type: EXPERIMENTAL
Intervention: Transconjunctival blepharoplasty with immediate CO(2) laser resurfacing
Number of subjects: 44

Group type: COMPARATOR
Intervention: Transconjunctival blepharoplasty alone
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Transconjunctival blepharoplasty with CO(2) laser resurfacing 2 months later
Number of subjects: 44
Study: 9669004

Group type: EXPERIMENTAL
Intervention: 0.06 mg.kg‐1 rocuronium
Number of subjects: 120

Group type: COMPARATOR
Intervention: NaCl 0.9% (control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: mivacurium 0.02 mg.kg‐1
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 8058290

Group type: EXPERIMENTAL
Intervention: 350-mm2 Baerveldt implant
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: 500-mm2 Baerveldt implant
Number of subjects: 73
Study: 3052167

Group type: EXPERIMENTAL
Intervention: Propofol (1.5 mg/kg for induction, followed by 10‐min infusion of an induction dose; maintained with continuous infusion of 0.1 mg/kg per min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Etomidate (18 mg for induction, followed by 2.4 mg/min for maintenance)
Number of subjects: 20
Study: 31785175

Group type: EXPERIMENTAL
Intervention: Deep inhalations during mannitol challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Deep inhalations during methacholine challenge
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: FeNO levels
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Responsiveness to deep inhalation methacholine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dose‐response slopes from deep inhalation mannitol
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dose‐response slope from non‐deep inhalation mannitol
Number of subjects: 20